Johnson & Johnson is an American multinational healthcare company specializing in pharmaceuticals and medical technologies.

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

But even with the extra costs, which the medical-technology and drug company JNJ estimates to be about $400 million, Johnson & Johnson still raised its outlook for sales in 2025, while keeping its ...

Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of a downgrade, S&P ...

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other key stocks that Jim Cramer analyzes. In his latest appearance on CNBC’s Squawk on the ...

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

Health care giant Johnson & Johnson (JNJ) expects about $400 million in tariff-related costs this year. The costs will be felt primarily within the company's medical technology unit, which makes a ...